Clear Harbor Asset Management LLC Makes New $320,000 Investment in HCA Healthcare, Inc. (NYSE:HCA)

Clear Harbor Asset Management LLC acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 1,065 shares of the company’s stock, valued at approximately $320,000.

A number of other large investors have also added to or reduced their stakes in the company. Renaissance Technologies LLC acquired a new position in shares of HCA Healthcare during the second quarter worth $4,112,000. Benjamin F. Edwards & Company Inc. purchased a new stake in HCA Healthcare in the second quarter valued at about $33,000. Pacer Advisors Inc. increased its holdings in shares of HCA Healthcare by 11.3% during the second quarter. Pacer Advisors Inc. now owns 14,517 shares of the company’s stock valued at $4,664,000 after acquiring an additional 1,476 shares in the last quarter. Sei Investments Co. boosted its stake in HCA Healthcare by 41.3% in the 2nd quarter. Sei Investments Co. now owns 77,933 shares of the company’s stock worth $25,039,000 after purchasing an additional 22,770 shares in the last quarter. Finally, ProShare Advisors LLC raised its holdings in shares of HCA Healthcare by 5.0% in the second quarter. ProShare Advisors LLC now owns 30,229 shares of the company’s stock worth $9,712,000 after buying an additional 1,433 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts have weighed in on the company. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their price target for the company from $400.00 to $320.00 in a research note on Monday, November 25th. Morgan Stanley decreased their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. TD Cowen reduced their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a report on Monday, October 28th. Raymond James lowered HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. Finally, KeyCorp dropped their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $385.27.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.70% of the company’s stock.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $319.53 on Thursday. The business’s 50 day moving average price is $315.10 and its 200-day moving average price is $353.07. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The firm has a market capitalization of $80.94 billion, a PE ratio of 14.35, a P/E/G ratio of 1.06 and a beta of 1.64. HCA Healthcare, Inc. has a 1 year low of $278.68 and a 1 year high of $417.14.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were given a dividend of $0.66 per share. The ex-dividend date of this dividend was Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.83%. HCA Healthcare’s payout ratio is presently 11.85%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.